McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
720.82
-1.01 (-0.14%)
At close: Jun 24, 2025, 4:00 PM
720.82
0.00 (0.00%)
After-hours: Jun 24, 2025, 4:10 PM EDT
McKesson Employees
McKesson had 51,000 employees as of March 31, 2023. The number of employees decreased by 24,000 or -32.00% compared to the previous year.
Employees
51,000
Change (1Y)
-24,000
Growth (1Y)
-32.00%
Revenue / Employee
$7,040,216
Profits / Employee
$64,608
Market Cap
90.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
Mar 31, 2020 | 80,000 | 0 | - |
Mar 31, 2019 | 80,000 | 2,000 | 2.56% |
Mar 31, 2018 | 78,000 | 0 | - |
Mar 31, 2017 | 78,000 | 10,000 | 14.71% |
Mar 31, 2016 | 68,000 | -2,400 | -3.41% |
Mar 31, 2015 | 70,400 | 27,600 | 64.49% |
Mar 31, 2014 | 42,800 | -700 | -1.61% |
Mar 31, 2013 | 43,500 | 5,800 | 15.38% |
Mar 31, 2012 | 37,700 | 1,300 | 3.57% |
Mar 31, 2011 | 36,400 | 3,900 | 12.00% |
Mar 31, 2010 | 32,500 | 0 | - |
Mar 31, 2009 | 32,500 | -400 | -1.22% |
Mar 31, 2008 | 32,900 | 1,100 | 3.46% |
Mar 31, 2007 | 31,800 | 5,400 | 20.45% |
Mar 31, 2006 | 26,400 | 1,200 | 4.76% |
Mar 31, 2005 | 25,200 | 600 | 2.44% |
Mar 31, 2004 | 24,600 | 100 | 0.41% |
Mar 31, 2003 | 24,500 | 500 | 2.08% |
Mar 31, 2002 | 24,000 | 1,000 | 4.35% |
Mar 31, 2001 | 23,000 | 1,900 | 9.00% |
Mar 31, 2000 | 21,100 | -3,500 | -14.23% |
Mar 31, 1999 | 24,600 | 10,900 | 79.56% |
Mar 31, 1998 | 13,700 | 400 | 3.01% |
Mar 31, 1997 | 13,300 | 2,000 | 17.70% |
Mar 31, 1996 | 11,300 | -900 | -7.38% |
Mar 31, 1995 | 12,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MCK News
- 3 days ago - Our Top 10 High Growth Dividend Stocks - June 2025 - Seeking Alpha
- 6 days ago - 20 companies in the S&P 500 whose investors have gained the greatest rewards from stock buybacks - Market Watch
- 13 days ago - McKesson to Host Investor Day on September 23, 2025 - Business Wire
- 21 days ago - McKesson Corporation Completes Acquisition of Core Ventures - Business Wire
- 5 weeks ago - McKesson: Sustained Rally Backed By Strong Financials - Seeking Alpha
- 5 weeks ago - Our Top 10 High-Growth Dividend Stocks -- May 2025 - Seeking Alpha
- 5 weeks ago - McKesson To Spin-Off Its Medical-Surgical Solutions Business - Forbes
- 6 weeks ago - McKesson Corporation (MCK) CFO Britt Vitalone Hosts BofA Securities 2025 Healthcare Conference (Transcript) - Seeking Alpha